Meeting of the Advisory Committee on Minority Health, 39107 [2011-16744]
Download as PDF
srobinson on DSK4SPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 128 / Tuesday, July 5, 2011 / Notices
respondent from making such
representations unless the
representation is non-misleading, and,
at the time of making such
representation, respondent possesses
and relies upon competent and reliable
scientific evidence that substantiates
that the representation is true. For
purposes of Part II, the proposed order
defines ‘‘competent and reliable
scientific evidence’’ as at least two
randomized, double-blind, placebocontrolled human clinical studies that
are conducted by independent, qualified
researchers and that conform to
acceptable designs and protocols, and
whose results, when considered in light
of the entire body of relevant and
reliable scientific evidence, are
sufficient to substantiate that the
representation is true.
Part III of the proposed order
prohibits respondent from making
representations, other than
representations covered under Parts I or
II, about the health benefits of any drug,
dietary supplement, or cosmetic, unless
the representation is non-misleading,
and, at the time of making such
representation, respondent possesses
and relies upon competent and reliable
scientific evidence that is sufficient in
quality and quantity based on standards
generally accepted in the relevant
scientific fields, when considered in
light of the entire body of relevant and
reliable scientific evidence, to
substantiate that the representation is
true. For purposes of Part III, the
proposed order defines ‘‘competent and
reliable scientific evidence’’ as ‘‘tests,
analyses, research, or studies that have
been conducted and evaluated in an
objective manner by qualified persons,
and that are generally accepted in the
profession to yield accurate and reliable
results.’’
Part IV of the proposed order states
that the order does not prohibit
respondent from making representations
for any drug that are permitted in
labeling for that drug under any
tentative or final standard promulgated
by the Food and Drug Administration
(‘‘FDA’’), or under any new drug
application approved by the FDA. This
part of the proposed order also states
that the order does not prohibit
respondent from making representations
for any product that are specifically
permitted in labeling for that product by
regulations issued by the FDA under the
Nutrition Labeling and Education Act of
1990.
Part V of the proposed order requires
respondent to pay nine hundred
thousand dollars ($900,000) to the
Commission to be used for equitable
relief, including restitution, and any
VerDate Mar<15>2010
17:58 Jul 01, 2011
Jkt 223001
attendant expenses for the
administration of such equitable relief.
Parts VI, VII, VIII, and IX of the
proposed order require respondent to
keep copies of relevant advertisements
and materials substantiating claims
made in the advertisements; to provide
copies of the order to its personnel; to
notify the Commission of changes in
corporate structure that might affect
compliance obligations under the order;
and to file compliance reports with the
Commission. Part X provides that the
order will terminate after twenty (20)
years, with certain exceptions.
The purpose of this analysis is to
facilitate public comment on the
proposed order, and it is not intended
to constitute an official interpretation of
the agreement and proposed order or to
modify their terms in any way.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2011–16739 Filed 7–1–11; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Committee on
Minority Health
Office of Minority Health,
Office of the Assistant Secretary for
Health, Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice of meeting.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (DHHS) is hereby giving notice
that the Advisory Committee on
Minority Health (ACMH) will hold a
meeting. This meeting is open to the
public. Preregistration is required for
both public attendance and comment.
Any individual who wishes to attend
the meeting and/or participate in the
public comment session should e-mail
acmh@osophs.dhhs.gov.
DATES: The meeting will be held on
Monday, August 29, 2011 from 9 a.m. to
5 p.m. and Tuesday, August 30, 2011
from 9 a.m. to 1 p.m.
ADDRESSES: The meeting will be held at
the Doubletree Hotel, 1515 Rhode Island
Ave., NW., Washington, DC 20005.
FOR FURTHER INFORMATION CONTACT: Ms.
Monica A. Baltimore, Tower Building,
1101 Wootton Parkway, Suite 600,
Rockville, Maryland 20852. Phone: 240–
453–2882 Fax: 240–453–2883.
SUPPLEMENTARY INFORMATION: In
accordance with Public Law 105–392,
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
39107
the ACMH was established to provide
advice to the Deputy Assistant Secretary
for Minority Health in improving the
health of each racial and ethnic
minority group and on the development
of goals and specific program activities
of the Office of Minority Health.
Topics to be discussed during this
meeting will include increasing the
health care workforce and strategies to
improve the health of racial and ethnic
minority populations through the
development of health policies and
programs that will help eliminate health
disparities, as well as other related
issues.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
designated contact person at least
fourteen (14) business days prior to the
meeting. Members of the public will
have an opportunity to provide
comments at the meeting. Public
comments will be limited to three
minutes per speaker. Individuals who
would like to submit written statements
should mail or fax their comments to
the Office of Minority Health at least
seven (7) business days prior to the
meeting. Any members of the public
who wish to have printed material
distributed to ACMH committee
members should submit their materials
to the Executive Secretary, ACMH,
Tower Building, 1101 Wootton
Parkway, Suite 600, Rockville,
Maryland 20852, prior to close of
business August 24, 2011.
Dated: June 20, 2011.
Garth N. Graham,
Deputy Assistant Secretary for Minority
Health, Office of Minority Health, Office of
the Assistant Secretary for Health, Office of
the Secretary, U.S. Department of Health and
Human Services.
[FR Doc. 2011–16744 Filed 7–1–11; 8:45 am]
BILLING CODE 4150–29–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
HIT Standards Committee’s Workgroup
Meetings; Notice of Meetings
Office of the National
Coordinator for Health Information
Technology, HHS.
ACTION: Notice of meetings.
AGENCY:
This notice announces forthcoming
subcommittee meetings of a Federal
advisory committee of the Office of the
National Coordinator for Health
Information Technology (ONC). The
E:\FR\FM\05JYN1.SGM
05JYN1
Agencies
[Federal Register Volume 76, Number 128 (Tuesday, July 5, 2011)]
[Notices]
[Page 39107]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-16744]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Advisory Committee on Minority Health
AGENCY: Office of Minority Health, Office of the Assistant Secretary
for Health, Office of the Secretary, Department of Health and Human
Services.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (DHHS) is hereby giving notice
that the Advisory Committee on Minority Health (ACMH) will hold a
meeting. This meeting is open to the public. Preregistration is
required for both public attendance and comment. Any individual who
wishes to attend the meeting and/or participate in the public comment
session should e-mail acmh@osophs.dhhs.gov.
DATES: The meeting will be held on Monday, August 29, 2011 from 9 a.m.
to 5 p.m. and Tuesday, August 30, 2011 from 9 a.m. to 1 p.m.
ADDRESSES: The meeting will be held at the Doubletree Hotel, 1515 Rhode
Island Ave., NW., Washington, DC 20005.
FOR FURTHER INFORMATION CONTACT: Ms. Monica A. Baltimore, Tower
Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852.
Phone: 240-453-2882 Fax: 240-453-2883.
SUPPLEMENTARY INFORMATION: In accordance with Public Law 105-392, the
ACMH was established to provide advice to the Deputy Assistant
Secretary for Minority Health in improving the health of each racial
and ethnic minority group and on the development of goals and specific
program activities of the Office of Minority Health.
Topics to be discussed during this meeting will include increasing
the health care workforce and strategies to improve the health of
racial and ethnic minority populations through the development of
health policies and programs that will help eliminate health
disparities, as well as other related issues.
Public attendance at the meeting is limited to space available.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the designated contact person at least fourteen (14) business
days prior to the meeting. Members of the public will have an
opportunity to provide comments at the meeting. Public comments will be
limited to three minutes per speaker. Individuals who would like to
submit written statements should mail or fax their comments to the
Office of Minority Health at least seven (7) business days prior to the
meeting. Any members of the public who wish to have printed material
distributed to ACMH committee members should submit their materials to
the Executive Secretary, ACMH, Tower Building, 1101 Wootton Parkway,
Suite 600, Rockville, Maryland 20852, prior to close of business August
24, 2011.
Dated: June 20, 2011.
Garth N. Graham,
Deputy Assistant Secretary for Minority Health, Office of Minority
Health, Office of the Assistant Secretary for Health, Office of the
Secretary, U.S. Department of Health and Human Services.
[FR Doc. 2011-16744 Filed 7-1-11; 8:45 am]
BILLING CODE 4150-29-P